| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biochemistry, The Weizmann Institute of Science, Rehovot 76100, Israel
Address all correspondence and requests for reprints to: Dr. Yoram Shechter, The Weizman Institute of Science, Department of Biochemistry, 76100 Rehovot, Israel.
Vanadate, which mimics the biological effects of insulin, also inhibits lipolysis in rat adipocytes. Here we demonstrate that the antilipolytic effect of vanadate differs from that of insulin at least by the five following criteria: 1) vanadate inhibits lipolysis mediated by high (supraphysiological) concentrations of catecholamines; 2) vanadate antagonizes (Bu)2cAMP-mediated lipolysis; 3) vanadate antagonizes isobutylmethylxanthine-dependent lipolysis, 4) vanadate inhibits lipolysis mediated by okadaic acid; and 5) wortmannin, which blocks the antilipolytic effect of insulin, fails to block vanadate-mediated antilipolysis. Vanadate does activate phosphoinositol 3-kinase, and wortmannin blocks this activation.
Our working hypothesis assumes that all of the insulin-like effects of
vanadate, including antilipolysis, are initiated by the inhibition of
protein phosphotyrosine phosphatases (PTPases). Among documented PTPase
inhibitors we found that VOSO4 (oxidation state +4),
several organic vanadyl compounds (+4), zinc (Zn2+),
tungstate (W), and molybdate (Mo) also had antilipolytic activity. The
order of potency was vanadyl acetylacetonate
VOSO4
NaVO3
vanadyl-dipicolinate > Zn2+
W > Mo, and it correlated better with the inhibition of adipose
membranal-PTPases in cell-free experiments. We have concluded that the
antilipolytic effect of vanadate is 1) mechanistically distinct from
that of insulin, 2) independent of phosphoinositol 3-kinase activation,
and 3) independent of the lipolytic cascade. We also strongly suggest
that the antilipolytic effect of vanadate emanates from inhibiting
adipose membranal, rather than cytosolic PTPases, and present
preliminary data showing distinct differences in catalysis between
these two PTPase categories. Overall, the study indicates that
antilipolysis can be manifested via alternative, insulin-independent,
signal-transducing pathways.
This article has been cited by other articles:
![]() |
M. E. Waltner-Law, X. L. Wang, B. K. Law, R. K. Hall, M. Nawano, and D. K. Granner Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production J. Biol. Chem., September 13, 2002; 277(38): 34933 - 34940. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Cammisotto and L. J. Bukowiecki Mechanisms of leptin secretion from white adipocytes Am J Physiol Cell Physiol, July 1, 2002; 283(1): C244 - C250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lynch, B. J. Patson, S. A. Goodman, D. Trapolsi, and S. R. Kimball Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E25 - E34. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Sun, N. Sekar, I. Goldwaser, E. Gershonov, M. Fridkin, and Y. Shechter Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E403 - E410. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sekar, J. Li, Z. He, D. Gefel, and Y. Shechter Independent Signal-Transduction Pathways for Vanadate and for Insulin in the Activation of Glycogen Synthase and Glycogenesis in Rat Adipocytes Endocrinology, March 1, 1999; 140(3): 1125 - 1131. [Abstract] [Full Text] |
||||
![]() |
N. Sekar, S. Qian, and Y. Shechter Vanadate Elevates Lipogenicity of Starved Rat Adipose Tissue: Mechanism of Action Endocrinology, May 1, 1998; 139(5): 2514 - 2518. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |